NSE: INDGN
INDEGENE LIMITED
Latest available quote
INDEGENE LIMITED
NSE: INDGN
₹614.50
-7.75 (-1.25%)
Open
625.00
High
625.00
Low
612.30
Prev close
622.25
Last trade 9/11/2026, 3:29:46 pm IST. Last successful check 10/11/2026, 5:05:30 am IST. Prices from NSE via Upstox, checked every 30 seconds; provider delays may apply. For information only.
Price history
+11.69% over 3M
Performance
52-week range
Position in day range
INDGN stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Uptrend
50-DMA ₹595.94
RSI (14)
62
Neutral momentum
Volatility (ATR)
3.40%
Moderate
Close streak
1d down
Volume vs 20d avg
0.40x
From 52W high
-3.68%
Up from 52W low
+48.43%
Green days (20)
7/20
Monthly seasonality
Average monthly move for INDGN across the available price history.
Key statistics
Open
625
Day high
625
Day low
612.3
Prev close
622.25
Volume
1.87 L
Avg vol (20d)
4.66 L
52W high
638
52W low
414
INDGN quarterly results
All INDGN results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹1,122 cr
— YoY
Net profit
₹112 cr
— YoY
Operating profit
₹139 cr
— YoY
EPS
₹4.67
— YoY
Swipe sideways to see all columns →
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q2 FY272026-09-30 | ₹1,122 cr | ₹139 cr | ₹112 cr | 12.4% | 10.0% | ₹4.67 | — | -3.4% |
| Q1 FY272026-06-30 | ₹1,063 cr | ₹130 cr | ₹116 cr | 12.2% | 10.9% | ₹4.84 | -0.2% | +45.8% |
| Q4 FY262026-03-31 | ₹1,003 cr | ₹122 cr | ₹79.7 cr | 12.1% | 7.9% | ₹3.32 | — | -22.5% |
| Q3 FY262025-12-31 | ₹942 cr | ₹120 cr | ₹103 cr | 12.7% | 10.9% | ₹4.29 | — | -11.6% |
| Q1 FY262025-06-30 | ₹761 cr | ₹134 cr | ₹116 cr | 17.6% | 15.3% | ₹4.86 | — | — |
| TTM (last 4 quarters) | ₹4,131 cr | ₹511 cr | ₹411 cr | 12.4% | 10.0% | ₹17.12 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
Indegene Hit 52-Week High, Up 2.44% After Brokerage Call Update — Levels, Volumes and the Follow-Up to Track
Indegene (INDGN) last traded at ₹608.95, +14.85 (+2.44%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Indegene Share Price Trades Flat at ₹609.70: What Is Driving INDGN Today, and the Levels That Matter
Indegene (INDGN) trades at ₹609.70, -1.95 (-0.32%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Latest market news
Breaking: Ethereum Slides 5.17% to $2,118.92 (10 November 2026)
Ethereum (ETH) is down 5.17% at $2,118.92 as of 12:00 am IST, dragging the wider crypto board with it.
Quarterly Results Leads Market News Coverage With 13 Headlines
Broad coverage across Indian financial media placed quarterly results and sector trends in focus on 9 November 2026. Here is what moved the news desks.
Altrix Turnaround Watch: 15 NSE Stocks Gain Strength as 10 Falter
The Altrix daily scan on 9 November 2026 highlights 15 NSE stocks improving off a weak base alongside 10 names losing momentum before trend shifts become obvious.
Closing Market Buzz, 9 November 2026: Industry And Sectors Tops the Coverage Ahead of Quarterly Results and Banks And NBFCs
The most-covered market themes in the closing session on 9 November 2026 — industry and sectors, quarterly results, banks and NBFCs — with our live numbers for each and links to the publishers running the story.
Welspun Share Price Slips to ₹2,200.30 as WELCORP Trades on Light Volume
Welspun trades down at ₹2,200.30 (-2.03%) on NSE at 03:05 pm IST on 9 November 2026 on ordinary volume of 8,15,847 shares, holding within its session band.
Aarti Drugs Share Price Zooms 9.28%: What Is Driving AARTIDRUGS Today, and the Levels That Matter
Aarti Drugs (AARTIDRUGS) trades at ₹491.65, +41.75 (+9.28%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Price and history data from NSE via Upstox. For information only, not investment advice.